South & Central America Peripheral Embolization Coils Market Forecast to 2031 - Regional Analysis - by Type, Material, and Application

The South & Central America peripheral embolization coils market was valued at US$ 33.42 million in 2023 and is expected to reach US$ 44.64 million by 2031; it is estimated to register a CAGR of 3.7% from 2023 to 2031.

Expanding Range of Applications of Embolization Coils Fuel South & Central America Peripheral Embolization Coils Market

Companies operating in the peripheral embolization coils market constantly focus on new product launches and marketing approval, which helps them improve their sales. A few of the noteworthy developments in the peripheral embolization coils market are mentioned below. In January 2024, the National Medical Products Administration provided marketing approval for the ZYLOX Phoenix Peripheral Detachable Fibered Coil Embolization System manufactured by Zylox-Tonbridge Medical Technology Co Ltd. Peripheral vascular intervention is the most prevalent application of this embolization coil system. Embolization treatment of visceral aneurysms, endoleak management of abdominal aortic aneurysms, hemoptysis, and arteriovenous fistula are the other important clinical applications of the system, which are internationally recognized for their safety and efficacy. In April 2022, Boston Scientific Corporation received 510(k) clearance from the US Food and Drug Administration (FDA) for the EMBOLD Fibered Detachable Coil designed to block or reduce the blood flow rate in the peripheral vasculature. The newest addition to Boston Scientific’s interventional oncology portfolio was designed for use in various embolization procedures, necessarily minimally invasive treatments intended to block one or more blood vessels to obstruct or reduce blood flow. The EMBOLD Fibered Detachable Coil features a single platform consisting of three coils, making it simpler for physicians to address various patient needs and anatomies. Thus, new product developments and marketing approvals are anticipated to create opportunities for growth of the peripheral embolization coils market during the forecast period.

South & Central America Peripheral Embolization Coils Market Overview

The peripheral embolization coils market in South & Central America is segmented into Brazil, Argentina, and the Rest of South & Central America. Market growth in this region is attributed to the rising incidence of stroke, increasing prevalence along with mortality rates of tumors and gastric cancer, and ongoing developments in healthcare systems. According to the International Orthopaedic Trauma Association Supplement, trauma is the third most significant cause of mortality in Brazil, accounting for 12.5% of all-cause deaths. Trauma is the most significant cause of death for individuals aged 1-39, with a mortality rate of 70.5% per 100,000 people; men account for 83.1% of the total count of death cases. In Brazil, abdominal aortic aneurysms are the most common type of aortic aneurysms. The condition is more common in people over the age of 60. Smoking is a major risk factor for the development of abdominal aortic aneurysms, and rupture signifies their most severe complication. Gastric cancer (GC) ranks first and fifth among the major causes of cancer-related mortality in the Chilean and Argentinean male populations, respectively. The rest of South American countries are highly focused on improving their healthcare infrastructure by allowing new healthcare providers and businesses to enter these markets. In addition, they are taking interest in improving their healthcare services by making significant investments as well as focusing on primary and advanced care. Thus, the improving healthcare systems are likely to generate significant opportunities for the peripheral embolization coils market in the Rest of South America in the coming years.

South & Central America Peripheral Embolization Coils Market Segmentation

The South & Central America peripheral embolization coils market is categorized into type, material, application, and country.

Based on type, the South & Central America peripheral embolization coils market is bifurcated into detachable coil and pushable coil. The detachable coil segment held a larger market share in 2023.

In terms of material, the South & Central America peripheral embolization coils market is categorized into platinum, platinum & hydrogel, and platinum tungsten alloy. The platinum segment held the largest market share in 2023.

By application, the South & Central America peripheral embolization coils market is segmented into bleedings & trauma, malformations, tumours, visceral aneurysm, endoleak type II, and varicose veins. The bleedings & trauma segment held the largest market share in 2023.

Based on country, the South & Central America peripheral embolization coils market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America peripheral embolization coils market share in 2023.

Medtronic Plc; Penumbra, Inc.; Balt; Boston Scientific Corp; Wallaby Medical; and Terumo Corp., are some of the leading companies operating in the South & Central America peripheral embolization coils market.

Reasons to Buy

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America peripheral embolization coils market.
• Highlights key business priorities to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the South & Central America peripheral embolization coils market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the South & Central America peripheral embolization coils market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.